Related Experiment Video
Updated: Jul 7, 2026

Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding
Published on: June 9, 2017
Roles of c-Src in alpha1B-adrenoceptor phosphorylation and desensitization
R Alcántara-Hernández1, P Casas-González, J A García-Sáinz
1Departamento de Biología Celular, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Ap. Postal 70-248, México DF 04510.
The protein tyrosine kinase c-Src plays a key role in alpha1B-adrenoceptor (alpha1B-AR) phosphorylation and desensitization. Inhibiting c-Src impacts receptor interactions with G-protein-coupled receptor kinases (GRKs).
Area of Science:
- Pharmacology
- Molecular Biology
- Cell Signaling
Background:
- Alpha1B-adrenoceptors (alpha1B-ARs) are G-protein-coupled receptors involved in various physiological processes.
- Receptor phosphorylation and desensitization are critical mechanisms regulating receptor function.
- The role of protein tyrosine kinases, specifically c-Src, in alpha1B-AR regulation is not fully understood.
Purpose of the Study:
- To investigate the role of c-Src in the phosphorylation and function of alpha1B-ARs.
- To examine the association between c-Src, alpha1B-ARs, and G-protein-coupled receptor kinase (GRK) isozymes.
- To determine c-Src's contribution to alpha1B-AR desensitization.
Main Methods:
- Utilized kinase inhibitors (PP2, Src Inhibitor II) and a dominant-negative c-Src mutant to study receptor phosphorylation.
- Employed co-immunoprecipitation assays to assess the interaction between alpha1B-ARs, c-Src, and GRKs (GRK2, GRK3, GRK5).
- Measured intracellular-free calcium levels to evaluate receptor function and desensitization in response to agonists (noradrenaline, phorbol myristate acetate, endothelin-1) and c-Src inhibition.
Main Results:
- Inhibitors of c-Src and dominant-negative c-Src significantly reduced noradrenaline- and phorbol myristate acetate-mediated alpha1B-AR phosphorylation.
- c-Src, GRK2, GRK3, and GRK5 were found to co-immunoprecipitate with alpha1B-ARs.
- c-Src inhibition attenuated the agonist-induced increase in GRK2 and GRK3 co-immunoprecipitation with alpha1B-ARs.
- Pretreatment with a c-Src inhibitor amplified calcium signaling responses and enhanced desensitization to endothelin-1.
Conclusions:
- c-Src is implicated in the phosphorylation and desensitization of alpha1B-adrenoceptors.
- c-Src modulates the interaction between alpha1B-ARs and GRK isozymes.
- Targeting c-Src may represent a therapeutic strategy for modulating alpha1B-AR function.
More Related Videos
Related Concept Videos
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Sympathetic Signaling
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
GPCR Desensitization

